FDA Unveils Medical Device “Postmarket Transformation”

FDA's device center is establishing a senior-level team of agency staffers and outside experts to lead an effort to revitalize the postmarket device safety program, the agency announced Jan. 19

More from Archive

More from Medtech Insight